The two FDA-approved drugs for this indication are pamidronate (Aredia, Novartis), 90 mg infused over at least two hours every three to four weeks; ...
The other bisphosphonates include Actonel, sold by Procter & Gamble and Sanofi-Aventis; Novartis AG's Zometa, Aredia and Reclast; P&G's Didronel and ...
The class of drugs, called biophosphonates, include Novartis's Zometa, Aredia and Reclast; and Boniva from Roche and GlaxoSmithKline (GSK. ...
The class of drugs, called biophosphonates, include Novartis's Zometa, Aredia and Reclast; and Boniva from Roche and GlaxoSmithKline (GSK. ...
... Ganite compared with calcitonin and with two bisphosphonates (etidronate and pamidronate ). ...
... Procter & Gamble's Didronel (etidronate) and Actonel (risedronate), Roche/GlaxoSmithKline's Boniva (ibandronate) and Novartis' Aredia (pamidronate). ...
But the society said the claims were misleading, and warned that if cancer patients stayed off bisphosophonate medications such as Zometa and Aredia for ...
... Ganite compared with calcitonin and with two bisphosphonates (etidronate and pamidronate ). ...
... found among patients taking nitrogen-based bisphos- phonate medicines, including Fosamax, Actonel and Boniva and the IV cancer drugs Aredia and Zometa. ...
... Ganite compared with calcitonin and with two bisphosphonates (etidronate and pamidronate ). ...